Clinical Trial: First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536724) titled 'First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation' on March 27.

Brief Summary: The goal of this clinical trial is to assess if the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation (TRICENTO G2 TVSTR) is safe and efficient in treating severe tricuspid regurgitation in adult patients.

The main questions it aims to answer are:

* Does the treatment with the TRICENTO G2 TVSTR improve symptoms of severe tricuspid regurgitation?

* Is the treatment with the TRICENTO G2 TVSTR safe?

Participants will:

* Undergo a minimally...